Upstate Active Clinical Trials
Study Title:A Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate
the Efficacy and Safety of CC-220 in Subjects With Active Systemic Lupus Erythematosus
What is the purpose of the study?This study is being conducted to test the effect of CC-220 on improving your SLE, and to see how well your body tolerates CC-220.
Upstate Institutional Review Board (IRB) Number:1122481
Study Phase:Phase II
Patient Age Group:Adults
Principal Investigator:Andras Perl, MD, PhD
Who can I contact for more information?
Name: Ryan Kelly